Division of Metabolic Engineering by 服部 征雄 et al.
44 
薬物代謝工学分野 Division of Metabolic Engineering 
教授 服部 征雄 Professor Masao,Hattori (Ph. D.) 
助教授 横津 隆子 Associate Professor Takako Yokozawa (Ph. D.) 
助手 宮代 博継 As凶ant ｷProfessor Hirotsugu Miyashiro (Ph. D.) 
技官 中村 憲夫 Research Associate Norio Nakamura (Ph. D.) 
薬物代謝工学分野は和漢薬の薬効，毒性発現に関与する代謝系の分子生物学的研究を発展させる
ことを設置目的とし，①和漢薬の薬効発現に関与する腸内細菌の役割，②薬物代謝に関する腸内
細菌遺伝子の解明，③腎毒性物質産生機構の分子生物学的解明とその制御に関する研究を課題とし
て取りあげ，和漢薬の薬効発現機構、生体へのレスポンスなどの基礎的研究を通じて，和漢薬の科
学的評価や臨床応用をはかることを目指している。主な研究題目を以下に示す。
1. 天然物のバイオトランスフォーメイション
2. 和漢薬の薬効発現に関与する腸内細菌，酵素およびその遺伝子の解析
, 3.AIDS, C型肝炎の予防および治療薬の開発
4. 腎疾患における病態の解明と腎臓病治療薬の開発
5. 糖尿病性腎症の治療戦略
本年度の主な研究を列挙すると：
1. ヒト腸内細菌による杜仲の樹皮に多量に含まれるpinoresinol diglucoside のエストロゲン様
物質（エンテロジオール，エンテロラクトン）への変換を検討し，この化合物が加水分解，エー
テル環の開裂，脱メチル化，脱水酸基化反応を経て変換されることを明らかにした。また， こ
れらの代謝物のエストロゲン様作用，抗工ストロゲン様作用を検討した。
2. 霊芝に含まれる苦味成分の HPLC による分析法を確立し，霊芝製品の品質評価を行なった。ま
た台湾産樟芝から 5 種の新規化合物を単離し，その細胞毒性を検討した。
3. 中国少数民族薬物の C 型肝炎ウイルス由来の RNA ポリメラーゼ阻害活性を探索した。
4. 蛋白・糖修飾を surrogate マーカーとして利用し，腎不全並びに糖尿病性腎症における病態把
握に着手した。また新たな治療手段を探索するために，温牌湯， epicatechin 3-0-gallate，緑
茶ポリフェノール，桂枝夜苓丸，八昧地黄丸，芥子菜，韓国産生薬を中心に検討した。
く〉著書 Book
1 ）楊秀偉，斜美栄，服部征雄．：『中約成分代謝分析』中国医菊科技出版．，北京，（2003).
2 ）横津隆子：『長寿科学事典』医学書院，東京， 2003, pp. 919-:-922. 
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Nakamura N., and Hattori M.: Synthesis and evaluation of anti-I主IV-1 mlld anti-HSV-1 activiｭ
ties of 4H-[1,2,4]’triazolo[l,5’ a] pyrimidin-5圃one derivatives. Arzneim。 1Forsch. Drug. Res., 
52:833圃839, 2002. 
In a one pot procedure, 18 compounds of 7・（substituted phenyl)-2-substi旬ted-6,7-dihydro-4H- [1,2,4] triazolo [1,5-
a] pyrimidin・5-one derivatives (16・33) have been synthesized. 3(5)-Amino-5(3)-substituted-l,2,4・triazole derivaｭ
tives (7・12)were used as synthones which were cyclocondensed by fusion with substituted methyl cinnamate esters 
(13-15) to afford the target compounds (16-33). In an effort to develop new non-nucleoside antiviral agents, comｭ
pounds 16-33 were evaluated for their anti-HIV-1 and anti-HSV-1 activities. Complete inhibition of the proliferation 
of HIV-1 viruses was achieved by compounds 22, 23 and 24 at concentrations of 25, 25 and 50 ｵg/ml, respectively. 
7-Phenyl-2・（n-pentyl）幽：6,7・dihydro-4H-[1ム4]triazolo [ 1,5-a] pyrimidinふone·(19) exhibited potential activity against 
HSV・ 1 with 88% reduction in the viral plaques. The suggested marked specificity of this class of compounds as antiｭ
HIV・ 1 agents is discussed. 
2) Takahashi K., Ouyang X., Komatsu K., Nakamura N., Hattori M., Balh>a A., and Azuma J.: 
Sodium tanshinone HA sulfonate derived from Danshen (Salvia miltionhiza) attenuates hyｭ
pe凶rophyinduced by angiotensin II in cultured neonantal rat cardiac cteUs. Biochem. Pharm., 
64:745司750, 2002. 
和漢薬研究所年報 29巻（2002年） p.88 参照．
3) Kuboyama K., Tohda C., Zhao J., NakamuraｷN., Hattori M., and Komaltsu K.: Axon-oir denｭ
drite-predomina~t outgrowth induced by constituents from Ashwagamlllh!a. Neourochemistry, 
13:1715・1720, 2002. 
和漢薬研究所年報 29巻（2002年） p.87 参照．
4 ) Xie L., Ahn E.,. Akao T .,Abdel・Hafez A. A., Nakamura N., and Hattori M.: Transformation 
of arctiin to e~trogenic and antiestrogenic substances by human intesltiinal bacteria. Chem. 
Pharm. Bull., 51: 378・384, 2003. 
After anaerobic incubation of arctiin (1) from the seeds of Arctium Zappa with a huma~ fecal suspension, six metaboｭ
lites were formed, and their structures were identified as （十arctigenin (2), (2R,3R）ふ（3 ’，4'-dihydroxybe回yl)・3-
(3”,4"-dimethoxybenzyl)butyrolactone (3), (2R,3R)-2・（3 ’－hydroxybenzyl）・3・（3”，4”－dimethoxyben勾rl)butyrolactone
(4), (2R,3R)-2・（3'-hydroxybenzyl)-3・（3”－hydroxy-4”－me出oxybenzyl)butyrolactone (5), (2R,3R)-2・（3 ’－hydroxybe回yl)-
3-(3”,4”-dihydroxybenzyl)butyrolactone (6), and （ー）－enterolactone (7) by various spectroscopic means including two 
dimensional (2D)-NMR, mass spectrome甘y,and circular dichroism. A possible metabolic pathway was proposed on 
the basis of their structures and the time course -<:>f the -transformation. Enterolactones obtained 仕om the 
biotransformation of arctiin and secoisolariciresinol diglucoside (SDG, from the seeds of Linum usitatissium) by 
human intestinal bacteria were proved to be enantiomers, with the （・）幽（2R,3R)and （＋）ー（2S~3S)configurations, respecｭ
tively. Compound 6 showed the most potent proliferative effect on the growth of MCF-7 human breast cancerｷcells 
in culture among 1 and six metabolites, while it showed inhibitory activity on es仕adiol-mediated proliferation of 
MCF-7 cels at a concentration of 10 ｵM. ｷThese results indicate that the transformation of]_ by intestinal flora might 
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be essential for the manifestation of the estrogenic and antiestrogenic activity of 1. 
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5) Tewtrakul S., Miyashiro H., Nakamura N., Hattori M., Kawabata T., Otake T., Yoshinaga T., 
Fujiwara T., Supavita T., Yuenyongawad S., Rattanasuwon P., and Dej-Adisai S.: HIV・
integrase inhibitory substances from Coleus parvifolius. Phytother. Res., 17:232・239, 2003. 
For the purpose of discovering anti-HIV-I agents 企om natural sources, water and ｷEtOH extracts of 50 Thai plants 
were ｷscreened for their inhibitory activity against HIV-I ip.tegrase (IN), an en勾rmeessential. for viral replication. Of 
these plants, an EtOH extract of Coleus parvifolius Benth. (aerial parts) showed potent activity against HIV-1 IN 
with an ICso value of 9 .2ｵg/mL. From this extract, 1 compounds were isolated and identified as luteolin 5-0・P・
n-glucopyranoside (i ), luteolin (2), luteolin 7-methyl ether (3), luteolin 5・0・f3-n-glucuronide ( 4),5-0-f3-Dｭ
glucopyranosyl・luteolin 7・methyl ether (5), rosmarinic acid (6), rosmarinic acid methyl ester (7), daucosterol (8), a 
mixture ofα， and f3-amyrins (9, 10) and phytol (11). Of these compounds, rosmarinic acid methyl ester (7), 
rosmarinic acid (6), luteolin (2) and luteolin 7・methylether (3) exhibited inhibitory activities against HIV-1 IN with 
ICso-values of 3.1, 5.0, 11.0 and 11.0 ｵM, respectively. Among rosmarinic acid derivatives, the HIV・ 1 IN inhibitory 
~ctivity increased in 旬m for a dimer (ICso = 5.0 ｵM), a trimer (ICso = 1.4 ｵM), and a tetramer (ICso = 1.0 ｵM). 
6) Xie L., Akao T., Hamasaki K., Deyama T., and Hattori M.: BiotransformatiOn of pinoresinol 
diglucoside to mammalian lignans by human intestinal microflora, and isolation of 
Enterococcus faecalis strain PDG圃1 responsible for the transformation of (+)-pinoresinol to 
（＋）ーlariciresinol. Chem. Pharm. Bull., 51: 508・515, 2003. 
By anaerobic incubation of pinoresinol diglucoside (1) from the bark of Eucommia ulmoides with a fecal suspension 
of humans, eleven metabolites were formed, and their structures were identified as ( + )-pinoresinol (2),( ＋）ー
lariciresinol (3), 3’-demethyl-( + )-lariciresinol ( 4),（ー）~secoisolariciresinol ( 5),（ー）－3”（3”， 4”－dihydroxybenzyl)-2・（4’－
hydroxy-3'-methoxybenzyl)butane-1,4-diol (6), 2-(3 ’，4’－dihydroxyben勾rl)-3_-(3 ’’
(7), 3－（~”－hydroxybenzyl)-2-( 4’－hydroxy回3’－methoxyben可l)butane-1,4・diol (8), .2・（3',4 '-dihydroxyben勾rl）・3-(3”－
hydroxybenzyl)butane-1,4-diol (9), （ー）－enterodiol (10), （ー）ー（2R,3R)-3.:(3”，4"-dihydroxybenzyl)-2・（4’－hydroxy-3 ＇幽
methoxybenzyl}-butyrolactone (11), （ー）ー（2R,3R)-f,田（3 ’，4'-dihydroxyben勾rl)-3-(3”，4＂四dihydroxybenzyl)butyro lac tone 
(12), （－）ー（2R,3R)-3・（3”－hydroxyben勾rl)-2・（4’－hydroxy-3にmethoxyben勾rl)butyrolactone (13), 2・（3 ’，4'-dihydroxybenzyl）ー
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3・（3”－hydroxybenzyl)butyrolactone (14), 2-(3 ’-hydroxybenzyl)-3-(3 ’’,4"-dihydroxybenzyl)butyrolactone (15) and (-) 
(2R,3R)-enterolact0ne (16) by various spectroscopic means, including two dimensional (2D)-NMR, mass spec仕ome­
甘y and . circular dichroism. A possible metabolic pathway was proposed on the basis of their s甘UC旬res and time 
coぽse experiments monitored by thin-layer chromatography. Furthermore, a bacterial strain responsible for the 
transformation of (+)-pi.noresinol to (+)-lariciresinol was isolated from a human fecal suspension and identified as 
Enterococcus faecalis strain PDG・ 1.
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7) Tan.aka N., Sekiya N., Hattori M., Goto H., Shibahara N., Shimada y。， and Terasawa K.: 
Measurement of plasm~ procyanidin B圃2 anｫ:f procyanidin B・3 levels aftleir oral administration 
in rat. Phytomedicine, 10: 122-126, 2003. 
Using a high-performance liquid chromatographic method and mass spectrometry analysis, we successfully measｭ
ured the absorption of orally administered procyailidin B・2and procyanidin B-3 isolated 仕omCinnamonoimi Cortex 
(the bark of Cinnamomum cassia Blume) in the rat plasma. This method used a TSK-GEL ODS・SOTS column, two 
solvents (A: 0.01 % acetic acid; B: methanol with-0.01 % acetic acid) in a linear gradient at a flow-rate of 1.0 ml/min, 
and fluorescence detection at excitation and emission wavelengths of 220 and 327 nm. 
8) Min B., Lee S., Kim J., Lee J., Kim T., Kim D., Kim Y., Joung H., Lee H., Nakamura N.,, 
Miyashiro H.; and Hattori M~ ： Anti-complement activity of constituentｧ from the stem-bark 
of Jug/ans mandshurica. Biol. Phann,. Bull., 26:1042-1044, 2003. 
Four known flavonoids and two galloyl glucoses Isolated 企om the stem-bark of Jug/ans mandshurica 
(Juglandacea吋， namely taxifoli,n (1), afzelin (2), quercitrin (3), myricitrin (4), 1,2,6・trigalloylglucose (5), and 
1,2ム6・tetragalloylglucose (6), were evaluated for their anti-complement activity against a complement system. 
Afzelin (2) and quercitrin (3) showed inhibitory activity against the complement system with 50% inhibitory concenｭ
tration (ICso) values of 258 and 440 ｵM. 1,2,6・Trigalloylglucose (5) and 1,2;3,6-tetragalloylglucose (6) exhibited 
anti-complement activity with ICso ｷvalues of 136 and 34 ｵM. In terms of the evaluation of the struc旬re-activity
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relationship of 3ム7・trihydroxyflavone,compounds 2, 3, and 4 were hydrolyzed wjth naringinase to give kaempferol 
(2a), quercetin (3a), and myricetin (4a) as their aglycones, and tliese were also .tested for their anti-complement ac・
tivity. Of the three aglycones, kaempferol (2a) exhibited weak anti-complement activity with an ICso value of 730 
ｵM, while quercetin (3a) and myricetin (4a) were inactive in this assay system. Among the compounds tested, 
1ム3,6・tetragalloylglucose (6) showed the most potent anticomplement activity (ICso, 34 ｵM). 
9) Tazawa T., Zhao H., Li Y., Meselhy M. R., Nakamura N., Akao T., and Hattori M.: A new 
enzyme immunoassay for aconitine and its applicatfon to quantitative determination of 
aconitine levels in plasma. Biol. Phf!-rm. Bull., 26:1289・1294, 2003. 
A reliable enzyme immunoassay (EIA) method was developed for quantitative determination of aconitine with high 
sensitivity and specificity .The bovine serum albumin (BSA)-and p-galactosidase (p-Gal) con ugates as 
immunogens and enzyme-labeled antigens were prepared by coupling of their proteins with succinic acid (short 
chain length; n=2, where n represents the number of methylene units) and hexadecanedioic acid (long chain length; 
n=14) hemiesters of benzoylaconine through the respective N-hydroxysuccinimide esters as intermediates. Two 
types of the BSA-conjuagates with short and long chains were repeatedly injected into rabbit~ to obtain anti-, 
aconitine antisera (Asl and As2, respectively). All combinations of P-Gal-labeled antigens LAgl (n=2) and LAg2 
(n=l4) with antisera Asl (n=2) and As2 (n=14) showed high sensitivity to aconitine in a range of 0. ト1.0 ng. 
Although the combination of LAg2 (n=l4) with antiserum Asl (n=2) showed high specificity to aconitine, the comｭ
bination of LAg2 (n=14) and As2 (n=l4) was highly specific to both aconitine and mesaconitine. When aconitine 
was intravenously administered to rats, the aconitine concentration in their plasma remarkably decreased within the 
first 60 min, and then gradually declined, suggesting a two-compartment pharmacokinetic model in (Ve 0.41 ｱ 
0.091/kg, Vdss 1.7ｱ0.41/kg, CLtot 10土2 ml/min・ kg,AUCo-4soo 2055ｱ294.3 ng ・min/ml). Following oral administra-
tion of aconitine to rats at two doses of 0.1 and 1.0 mg/kg b.w., the maximum plasma concen仕ations ( Cmax) were 
0.73 土0.08 and 3.3 土 0·.6 ng/ml at times of 45 ｱ 9 and 150土 52 min, respectively, and the AUCo・1440 values were 
130ｱ4and,1600ｱ270 ng ・ min/ml. The bioavailavility （丹 ofaconitine was determined to be 0.013, where only 
1.3% of the aconitine administered orally was absorbed into the bo4y fluid. 
10) Zhao J., Sun X., Nakamura N., Zuo F., Yang X.;, Akao T., and Hattori M.: Development of 
an enzyme immunoassay system for mesaconitine and its application to the disposition study 
on mesaconitine. J. Trad. Med., 20:201・207, 2003. 
For the purpose of quantitative determination of mesaconitine, an extremely toxic and major ‘alkaloid in aconite 
tuber, a highly sensitive enzyme immunoassay (EIA) was developed as follows; Firstly, a hapten [Nｭ
desethylaconitine N-glutarate (DEAG)J was synthesized by introduction of a glutaryl group to the nitrogen atom of 
aconitine after .elimination of an N-ethyl group. Subsequently it was coupled with bovine serum albumin (BSA) and 
p-galactosidase (p-Gal) to give an immunogen (DEAG-BSA) and a labeled antigen (DEAG・P・Gal), respectively. 
After immunization Of female albino rabbits with DEAG-BSA for six months to elicit a polyclonal antiser:um (Asｭ
DEAG), the experimental conditions were optimized for a highly sensitive EIA. At 103-fold dilution of DEAG-P-Gal 
and 2.5ﾗ104-fold dilution ・ofAs-DEAG, the assay exhibited a linear range of 0.005-5 ng/tube for mesaconitine. 
Under the same conditions, the antiserum had a 24.4 % cross-reaction with aconitine and virtually no reaction with 
benzoylmesaconine. 
Next, the EIA method was applied to the disposition study on mesacon:itine to monitor the plasma concentration 
after oral administration of mesaconitine at 1 mg/kg to rats, its low bioavailability being suggested 企om Cmax and 
A UC values obtained. 
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11) Ahn E., Nakamura N., Akao T., Komatsu K., Qui M., and Hattmri M.: JP'renylated flavonoids 
from Moghania philippinensis. Phytochemistry, 64:1389・1394, 2003. 
Five prenylated flavonoids, 8・（ 1,1 ・dimethylallyl)genistein (1), 5,7,3 ’，4’－tetrahydroxy♂’，5'-di(3-methylbut-2・enyl)-
isoflavone (2), 5,7,3'-trihydroxy-2'-(3・methylbut-2・enyl）・4',5'-(3,3-dimethylpyrano)isoflavone (3), (2R）・5,2',4’－trihydroxy-
8,5’－di(3-methylbut-2-enyl)・6,7・（3,3・dimethylpyrano)flavanone (4a) and (2S)-:5,2',4’ー仕ihydroxy-"8，ターdi(3-methylbut-
2・enyl)-6,7-(3,3-dimethylpyrano) flavanone (4b), were isolated from the roots of Moghania phi!伊']Jinensis. The 
S仕uctures of these compounds were determined on the basis of spectroscopic and chemical means. 
12) Takako K., Jyo M., Nakamura N., Komatsu K., Hattori M., ShD.motoln([])no K., Shimotohono 
K., and Kakiuchi N.: Inhibitory effect of Tibetan medicinal pla四ts on viral polymerases. J. 
Trad. Med., 20:243・250, 2003. 
For the puゅose of development of novel anti-virus agents from ethnical drugs, we examined 76 traditional Tibetan 
medicines for inhibitory effect on two viral enzymes, reverse transcriptase (RTase) of HIV and RNA dependent 
RNA polymerase (RdRp) of HCV. Although 28 methanol ex仕acts inhibited RTase more than 70% at a concentraｭ
tion of 100 ｵg/ml, only 3 samples, T42（蔵青果， Terminaliachebula RETZ.), T46 （横榔， Arecacatechu L.) and T61 
（紅横榔）， were found stil inhibitory after eliminating the effect of tannins by addition of BSA in the en勾rme reacｭ
tion mixtur・e. In the case of the RdRp, 7 extracts (ICso values of les than 10 ｵg/ml) contained les than 20% tannins. 
The extract of Rhodiola sacra, whose ICso for RTase was 25.9 ｵg/ml, was subject to phytochemical investigation. 
Out of 8 compounds isolated from the extract, daucosterol was found effective for RTase. 
13) Lipipun V., Kurokawa M., Suttisri R., Taweehotipatr P., Pramyothinn P., Hattori M., and 
Shiraki K.: Efficacy of Thai medicinal plant extracts against herpes simrn]plex virus type 1 in圃
fection in vitro and in vivo. Antiviral Research~ 60:175・180, 2003. 
Twenty Thai medicinal plant extracts were evaluated for anti-herpes simplex virus type 1 (HSV-1) activity. Eleven 
of them inhibited .Plaque formation of HSV-1 more than 50% at 100 ｵg/ml in a plaque reduction assay. Aglaiα 
odorata, Moringa oleifera, and Ventilago denticulate among the 1 were also effective against thymidine kinaseｭ
deficient HSV-1 and phosphonoacet~te-resistant HSV」 strains. These therapeutic efficacies were characterized 
using a cutaneous HSV・ 1 infection in mice. The extract of M oleifera at a dose of 750 mg/kg per day significantly 
delayed the development of skin lesions, prolonged the mean survival times and reduced the mortality of HSV-1 irト
fected mice as compared with 2% DMSO in distmed water (P < 0.05), The extracts of A. odorata and V denticulate 
were also significantly effective in limiting the development of skin lesions (P < 0.05). There were no significant 
difference between acyclovir and these three plant ex仕acts in the delay of the development of skin lesions and no 
significant difference between acyclovir and M oleifera in mean survival times. Toxicityｷ o(these plant extracts were 
not observed in treated mice. Thus, these three plant extracts may be possible candidates of anti-HSV・1 agents. 
14) Park J. C., Miyashiro H~， and Hattori M.: Inhibitory effects of mdlluanol extracts from 
Korean medicinal plants against HIV-1 protease activity. Korean J. Mred. Crop Sci., 11:264-
267, 2003. 
Korean medicinal plants were screened for their inhibitory activity against HIV-l protease. The inhibitory activity 
of protease was determined by incubating the extracts in reaction mixtures containing protease and substrate Hisｭ
Lys-Ala-Arg-Val・Leu-(p-N02-Phe）四Glu-Ala-Nle-Ser-NH2to perform proteolytic cleavage reactions. In this study the 
twenty six extracts from medicinal plants were investigated. Of the extracts tested, the extracts from the stem of 
Morus alba exhibited the strongest activity with inhibition of 81 % at a concentration of 100 ｵg/ml. The extracts of 
the flower of Si似折。ga stolonifer，α， and stems of Euonymus japonica and Castamea crenata showed appreciable inｭ
hibitory activity (>50%) against HIV-1 protease at the same con.centration. 
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15) Yokozawa T., Rhyu D.Y., Cho E.J., Aoyagi K.: Protective Activity of （ー）－Epicatecbin 3・0圃
gallate against Peroxynitrite圃mediated Renal Damage. Free Radi，ι Res., 37:561・571, 2003. 
The protective effect of （ー）－epicatechin 3-0・gallate (ECg) against peroxynitrite (ONOO・）－mediateddamage was ex- -
aminedｷ using an animal rriodel and a cel culture system. In rats subjected to lipopolysaccharide (LPS) administra-
tion plus ischemia-reperfusion, the plasma 3-ni仕otyrosi_ne level, an indicator of ONOO-production in viνo, was 
elevated, whereas it declined significantly and dose-dependently after the oral administration of ECg at doses of 10 
and 20 mmoles/kg body weight/day for 20 days prior to the process. Moreover, oral administration of ECg signifiｭ
cantly enhanced the activities ｷof the antioxidant enzymes, superoxide dismutase, catalase and glutathione peroxidase, 
and the antioxidant gfotathione, showing enhancement of the biological defense system against the damage induced 
by ONOO-. In addition, the significant increase in the renal mitochondrial thiobarbituric acid-reactive substance 
level of LPS and ischemic” reperfused control rats was attenuated in rats given ECg. Furthermore, the elevatio~s in 
the plasma urea nitrogen and creatinine (Cr) levels and the urinary methylguanidine/Cr ratio induced by the proce・
dure were attenuated markedly after oral administration of ECg, implying amelioration of renal impairment. The adｭ
dition of ECg (25 or 125 mM) prior to 3-morpholinosydnonimine (SIN-1, 800 mM) exposure reduced ONooｭ
formation and. increased the viability of cultured renal epithelial -(LLC-PK1) cels in a dose-dependent manner. In 
particular, ECg inhibited ONoo--mediated apoptotic cel death, which was confirmed by decreasesｷ in the DNA 
fragmentation rate and the presence of apoptotic morphological changes, i.e., small nuclei and nuclear fragmentation. 
Furthermore, adding ECg before SIN-I treatment regulated the cel-cycle by enhancing G2/M phase a町est. This 
study provides evidence that ECg has protective activity against the renal damage induced-by excessive ONOO-in 
cellular and in vivo systems. 
16) Yokozawa T., Ishida A., Cho E.J., Nakagawa T.ｷ: The effects of Coptidis Rhizoma extract on 
I 
A hypercholesterolemic animal model. Phytomedicine, 10:17-22, 2003. 
The serum cholesterol(total, fre, esterified, low density lipoprotein (LDL) and oxidized LDL) levels of rats fed a 
diet containing, by weight, 1% cholesterol and 0.5% cholic acid increased compared with those o.f rats fed a normal 
diet. However, the levels, especially, of total cholesterol, LDL and oxidized LDL, were significantly reduced, in a 
dose-dependent manner, in rats given Coptidis Rhizoma extract orally at doses_of 50 and 100 mg/kg body weight/day仁
for 30 days. This result indicates that Coptidis Rhizoma extract is effective in reducing the pathological damage 
caused by hypercholesterolemia through lowering serum cholesterol levels. In addition, Coptidis Rhizoma extract 
reduced the level of livｷer cholesterol, whereas it did not reduce that of fecal cholesterol, suggesting that the cholesｭ
terol level-lowering effect resulted from the reduction of cholesterol synthesis, not the enhancement of its excr~tion. 
Furthermore, the serum thiobarbituric acid-reactive substance level decreased after oral administration of Coptidis 
Rhi:zoma extract, indicating ’ that Coptidis Rhizoma could prevent hypercholesterolemic disease through reducing 
lipid peroxidation. This study demonstrates that Coptidis Rhizoma may be a useful therapy for hypercholesterolemia 
by reducing oxidative stress and cholesterol levels. 
17) Yokozawa T., Cho E.J., Nakagawa T.: Influence of green tea polyphenol in rats with arginine-
induced renal failure . .1ｷAgric. Food Chem., 51:2421圃2425, 2003. 
To determine whether green tea polyphenol ameliorates the pathological conditions induced by excessive dietary 
arginine, green tea polyphenol was administered to rats at a daily dose of 50 or 100 mg/kg body weight for 30 days 
with a 2% w/w arginine diet. In arginine-fed control rats, urinary and/or serum levels of guanidino compounds, nitric 
oxide (NO), urea, protein and glucose increased significantly, while the renal activities of the oxygen speciesｭ
scavenging enzymes superoxide dismutase (SOD) and catalase decreased, compared with casein-fed rats. However, 
r剖s given green tea polyphenol showed significant and dose-dependent decreases in serum lev~ls of creatinine (Cr) 
and 町ea nitrogen and urinary excretion o~ Cr, and they exerted a slight reduction of nitrite plus nitrate, indicating 
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that green tea polyphenol reduced the production of uremic toxins and NO. :In addition, in arginine-fed rats the uriｭ
nary urea, protein and . glucose level increases were reversed by the adminis仕ation of green tea polyphenol. 
Moreover, in rats given green tea polyphenol the SODｷ and catalase activities suppressed by excessive arginine adｭ
ministration increased dose-dependently, implying the biological defense system was augmented as a result of 仕切
radical scavenging. These results suggest that green tea polyphenol would ameliorate renal failure induced by excesｭ
sive dietaηr arginine by decreasing uremic toxin, and NO production and increasing radical-scavenging erizyme acｭ
tivity. 
18) Nakagawa T., Yokozawa T., Terasawa K., Nakanishi K.: Therapeutic ~sefulness of Keishi・
bukuryo・gan for diabetic nephropathy. J. Pharm. Pharmacol., 55:219~Z27, 2003. 
Keishi-bukuryo-gan is a traditional herbal. medicine, whic4 is used clinically as a vascular system disorder~ 
eliminating drug. In this s旬dy, its effects on the progression of diabeti~ nephropathy in experimental rats were inves-
tigated. The diabetic nephropathy modelｷ used in this study shows functional and ·mo中hological changes of the 
kidney resembling those seen in patients with diabetic nephropathy. Increased proteinuria and serum urea nitrogen 
and creatinine levels and decreased creatinine clearance, which are important parameters of renal function, were obｭ
served in rats with diabetic nephropathy. Pathological examination. of the kidney revealed diffuse, nodular and 
exudative lesions and arteriolar hyalin()sis. The deterioration of renal function was ameliorated in rats treated with 
Keishi-bukuryo-gan for 15 weeks and these results agreed with the renal histological findings. In addition, metabolic 
abnormalities mediated by persistent hyperglycemia (the glycation reaction, excessive polyol pathway activity, oxiｭ
dative stress and lipid metabolic abnormalities) were also observed. However, Keishi°'bukuryo・ganreduced accumuｭ
lation of advanced glycation end-products, determined by measuring fluorescence, and serum lipid peroxidation, 
仕iglyceride and total cholesterol levels dose-4ependently. Thus, this study indicates the potential therapeutic usefulｭ
ness of Keishi・bukuryo・gan-for.retarding the progression of renalｷ damage. and suggests that its beneficial effects 
were due to its ability to improve metabolic abnormalities associated with diabetes. 
19) Yokozawa T., Rhyu D.Y., Chen C.P.:. Protective effects of Acant~（］）]panax Radix ext_ract 
against endotoxemia induced by lipopolysaccharide. Ph~totheれ Res., 17:353・357, 2003. 
Endotoxemia causes an enhanced production of reactive oxygen radicals, which contribute to multiple organ dysｭ
function. When rats were given intravenous lipopolysaccharide and tested 6 h later we found that the activities of 
catalase and glutathion~ peroxidase (GSH-Px) in kidney, were acutely suppressed while in serum the levels of nitric 
oxide (NO), lipid peroxidation, urea nitrogen and creatinine were signi白candy increased, indicating the excessive 
production of reactive. oxygen radicals and the presence of renal injury. Pretreatment of rats with Acanthopanax 
Radix extract administered orally for 30 days reduced the NO and lipid peroxidation levels, increased the activities 
of catalase and GSH-Px, and attenuated the renal dysfunction. these results suggested that scavenging of reactive 
oxygen radicals is part of the mechanism by whfoh Acanthopanax Radix extract works as an effective agent in preｭ
venting multiple organ dysfunction. 
20) Kim H . Y., Yokozawa T., Cho Eム Cheigh H.S., Choi. Jふ， ChungH.Y。： In Vitro and in Vivo 
Antioxidant effects of mustard leaf (Brassica Juncea). Phytother. Res., li7:465・471, 2003. 
To investigate the antioxidant activity of mustard leaf (Brassicajuncea), we prepared four 企actions(CH2Cb, EtOAc, 
BuOH andH20 丘actions) and examined their radical scavenging activities in vitro and in vivo. Based on the in νitro 
results of spin trapping and 1, 1 ・diphenyl-2・picrylhydrazyl radical, we ’·carried out an in vivo study with the BuOH 
fraction to investigate its effect on oxidative stress in rats with streptozotocin-induced diabetes. We found that in 
comparison with untreated diabetic control rats, oral administration of the BuOH fraction (100 or 200 mg/kg body 
weight/day for 10 days) induced a significant decrease in serum glucose and glycosylated protein, which is 
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glycosylated with hemoglobin as an indicator of oxidative s仕ess. Moreover, administration of the BuOH 合action
also effectively reduced the serum superoxide and nitrite/nitrate levels. Furthermore, the levels of thiobarbituric acidｭ
reactive substances in serum and liver were also significantly lower than in the control group. These results indicate 
that the BuOH fraction of mustard leaf controls glucose metabolism and reduces lipid peroxidation as well as the 
level of oxygen radicals, ameliorating the damage caused by oxidative stress in diabetes. 
21) Yokozawa T., Kim H.Y., Cho E.J., Yamabe N., Choi J.S.: Protective effects of mustard -leaf 
(Brassica juncea) against diabetic oxidative stress. J. Nutr. Sci. Vitaminol., 49:87-93, 2003. 
Of four 企actions (CH2Ch, ethyl acetate (EtOAc), butanol (BuOH) and H20）仕om mustard leaf (Brassica juncea), 
the EtOAc fraction showed the strongest inhibitory effects, which were concentration-dependent, on the formation 
of advanced glycation end products and 合eeradical-mediated protein damage in an in vitro system, indicating a poｭ
tential protective role of this 企actionagainst diabetes and/or its complications. Based on these results, we carried out 
an in vivo study to determine whether the EtOAc 丘action protected against diabetic 9,Xidative stress induced by 
streptozotocin. Oral administration of the EtOAc fraction at doses of 50 and 200 mg/kg body weight/day-for 10 days 
reduced serum levels of glucose and glycosylated protein, implying that the impaired glucose metabolism due to diaｭ
betes had been ameliorated. In addition, the EtOAc 丘action significantly reduced the thiobarbituric acid-reactive 
substance levels of serum and hepatic and renal mitochondria. Furthermore, the elevated levels of superoxide and niｭ
trite/nitrate were reduced, in a dose-dependent manner, by oral administration of the EtOAc 仕action. These findings 
suggest that the EtOAc 企action 合ommustard leaf might be beneficial in atfonuating the damage caused by oxidative 
stress involved in diabetes and its complications. 
22) Cho E.J.; Yokozawa T., Rhyu D.Y., Kim S.C., Shibahara N., Park J.C.: Study on the inhibiｭ
tory effects of Korean medicinal plants and their main compounds on the 1,1・diphenyl-2・
picrylhydrazyl radical. Phytomedinine, 10:544・551, 2003. 
A 1, l-diphenyl-2・picrylhydrazyl (DPPH) radical-generating system was used to evaluate the antioxidant properties 
of Korean medicinal plants, which have been widely used as folk medicines for several disorders, and compounds 
isolated from them. Among the .Rosaceae, Rosa rugosa and Rosa davurica showed strong DPPH radical-scavenging 
activity. The most effective medicinal plant of the families other than Rosaceae was Cedrela sinensis, followed in 
order by Nelumbo nucifera, Eucommia ulmoides, Zanthoxylum piperitum, Cudrania tricuspidata and Houttuynia 
cordαta. These results serve as a good index of the 企ee radical-scavenging activities of Korean medicinal plants. 
Furthermore, the polyphenols isolated 合om these plants~ procyanidin B-3, (+)-catechin, gallic acid, methyl gallate, 
quercetin, quercetin 3・0-P-n-glucoside, quercetin 3-0-P-n-galactoside, quercetin 3-0-rutinose and kaempferol, exｭ
t;rted strong DPPH radical-scavenging activity. These results suggest that the Korean medicinal plants and 
polyphenols isolated from them that exhibited effective radical-scavenging activity may be promising agents for 
scavenging free radicals and treating diseases associated with excess 企ee radicals. 
23) Nakagawa T .,Y okozawa T .,Oowada S., Goto HィShibahara N., Shimada Y., Terasawa K.: 
Amelioration of kidney damage in spontaneously diabetic WBN/Kob rats after treatment with 
_Keis hi占ukuryo・gan. J. Trad. Med., 20: 156・164, 2003. 
In this study, we investigated whether Keishi・~bukuryo・gan can retard the occu町ence and progression of diabetic 
nephropathy in spontaneously diabetic WBN/Kob rats. Administration of Keishi・bukuryo-gan did not affect body 
weight loss or blood glucose levels but effectively lowered urinary protein excretion and serum creatinine levels, and 
ameliorated glomerular, vascular and tubulointerstitial lesions. In addition, treatment of the diabetic rats with Keishiｭ
bukuryo-gan reduced renal levels of thiobarbituric acid reactive substances and advanced glycation end products sigｭ
nificantly and elevated renal superoxide dismutase activity significantly. These results suggest that Keishi-bukuryo-
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gan exerts antioxidant effects in the kidneys of diabetics .and may prove that the herbal medicine is useful for inhibｭ
iting the progression of diabetic kidney disease. 
24) Yokozawa T., Rhyu D.Y., Cho. E.J.: Protection by the Chinese preｧ(Cription We-Pi-Tang 
against renal tubular LLC-PK1 cell damage induced by 3・morpholinosydnonimine.J. Phann. 
Pharmacol., 55:1405・1412, 2003. 
We investigated the effects of Wen-Pi-Tang extract on the protective mechanisms of renal tubular LLC-PK1 cels, 
as renal 旬bular cells are the most vulnerable renal tissue to oxidative s仕ess. Exposure to 800 ｵM 3-
morpholinosydnonimine (SIN-1) resulted in a marked increase in cellular peroxynitrite (ONOO-) that converted 
nonfluorescent dihydrorhodamine 123 to fluorescent rhodamine 123, a detectable probe for the long-lived ONOO-. >
In addition, it resulted in apoptotic cel death, assessed by a DNA 丘agmentation assay. However，住eatment with 
Wen-Pi-Tang extract, at concentrations of 50 and 100 ｵg/ml, together with SIN-1 protected renal tubular cells 
against ONOO・ through scavenging ONOO・ and inhibiting apoptotic cel death in a dose-dependent Il:aner. 
Moreover, treatment with Wen-Pi” Tang extract both before and after exposure to SIN-1 was also protective: it re・
duced cellular ONOO-levels, increased cel viability and decreased the DNA 企agmentationrate. These results sug-
gest that Wen-Pi-Tang would be expected to have protective activity against ONoo-”induced renal tubular injury 
through the inhibition of ONOO-production and apoptotic cel death by both preventing and 仕eating renal i吋町－
Furthermore, morphological characteristics of apoptosis were observed in SIN-1 treated tubular cels, while the ad・
dition of Wen-Pi・Tangextract with SIN-1 attenuated these morphological changes. ONOO~ generated by SIN-1 also 
disturbed the cel cycle by decreasing the cellular G2/M phase ratio, while W erト·Pi-Tang extract regulated the cel 
cycle by G2／乱f phase arest. 
25) Soung D.Y., Rhee S.H., Kim J.S., Lee J.Y., Yang H.S., Choi J.S., Yok([])zawa T., Han Y.N., 
Chung H.Y.:ｷ Peroxynitrite scavenging activity of lithospermate B from Salvia miltiorrhiza. よ
Pharm. Pharmacol., 55:1427・1432, 2003. 
Perox戸ii甘ite (ONOO・） is produced by the reaction of superoxide (02-) with ni凶c oxide. ONoo-damages proteins 
through nitration or oxidation. For protection from ONoo-induced protein modifications, ONOO・ scavengers
should be supplemented. Evidence was obtained that lithospermate B extracted 企omSalvia miltiorrhiza showed the 
strongest scavenging activity among its constituents. Its ONoo-scavenging activity is via an electron donation 
mechanism. A dihydroxyl group and a double bond seem to be 'essential s仕切旬re requirements. The data 合om the 
experiments further confirmed a protective effect of lithospermate B on bovine serum albumin and low-density lipoｭ
protein against ONOO-. This study demonstrated that lithospermate B with hydroxyl groups and double bonds exe抗s
an anti-nitration effect by scavenging ONoo-. 
26) YokozawaｷT., Rhyu D.Y., Cho KJ., Satoh A.,.Hattori M.: Novel pharmm(Cological potential of 
Rhei Rhizoma against peroxynitrite-induced oxidative renal injury. J. Trad. Med., 20: 235・
242; 2003. 
This study was 1focused on the protective role of Rhei Rhizoma extract 企om peroxyni甘ite (ONOO・）－induced·renal 
damages. The employed in vivo ONoo--generation model of lipopolysaccharide plus ischemia-reperfusion resulted 
in the elevations of plasma 3-nitrotyrosine level and renal myeloperoxidase (MPO) activity as the indicators of in 
vivo ONoo-generation. However, the administration of Rhei Rhizoma extract at doses of 30 and 60 mg/kg body 
weight/day for 30 days significantly decreased the concentrations of 3-nitrotyrosine and MPO activity. In addition, 
the rats given Rhei Rhizoma extract inhibited xaiithine oxidase (XOD) activity but not inducible nitric oxide 
synthase activity. It suggests that Rhei Rhizoma extract might play the role as a superoxide anion scavenger through 
the inhibition of XOD activity as well as direct ONOO:-scavenger. The protective role of Rhei Rhizoma extract was 
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also shown in the increase of antioxidant, glutathione, and the reduction in the lipid peroxid(;ltion in renal mitochon幽
dria. Moreover, the in vivo ONOO・ generationsystem resulted in the renal functional impairment asses~ed by the inｭ
crease in plasma levels of urea nitrogen and creatinine, whereas the rats administered Rhei Rhiz0ma extract 
decreased the levels significantly, implying the alleviation of renal dysfunction induced by ONoo-. This study sugｭ
gests that Rhei Rhizoma would play the role as an effective therapeutic potential for the oxidative stress-induced 
renal failure. 
27) Cho E.J., YokozawaT., Rhyu D.Y., Kim H.Y., Shibahara N., Park J.C.: The inhibitory effects 
of Koreｷan medicmal plants and their component compounds on lipid peroxidation. Am. J. 
Chin. Med., 31:907圃917, 2003. 
The a,ntioxidative activities of twelve medicinal plants and compounds isolated 企om them were investigated using 
’ the thiocyanate method to evaluate inhibitory effects on lipid peroxidation in the linoleic acid system. The peroxide 
levels gradually increased during incubation in the presence of linolejc acid over 3 days and. most of the plants inｭ
hibited lipid perqxidation. In particular, of the plants tested, Cudraniα tricuspidat，α， Zant ho砂！um p伊eritum,
Houttuynia cordata and Ulmus parvifolia reduced lipid peroxidation more effectively as lipid peroxidation proｭ
gressed, resulting in inhibition of about 80% relative to the control value by the 3rd day Of incubation. In addition, 
the polyphenols isolated from the plantsｷ also showed marked and dose-dependent inhibitory effects on lipid 
peroxidation. The compounds with the s仕ongestactivities were 3,4・dihydroxylbenzoicacid, quercetin, the quercetin 
glycosides quercetin 3・0－~－D-galactoside, quercetin 3-0－α・L-rhamnoside, quercetin 3-0-P・D-glucosideand quercetin 
3-0・rutinose, catechin, gallic acid, methyl gallate and rosamultin isolated from Zantho巧1lumpiperitum, Houttuynia 
cordata, Rosa rugosa and Cedrela sinensis. Moreover, quercetin glycosides showed stronger activity than quercetin, 
suggesting that glycosylation increases the antioxidative activity of quercetin. Our results indicate that the medicinal 
plants and their polyphenols show promise as therapeutic agents for various disorders involving free radical reacｭ
tions. 
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29) Jo M., Kimura T., Kakiuchi N., Komatsu K., Nakamura N., Hattori M., Shimotohno K., Shimotohno K.: 
Searching for new HCV agents, The Sixth JSPS-NRCT Joint Seminar, Recent Advances in Natural Medicine 
Research, 2003, 12, 2・4, Bangkok, Thailand. 
く〉その他 Others 
1 ）服部征雄：ヒト腸内細菌による和漢薬成分の代謝．東京薬科大学大学院特別講義， 2003, 6, 23，八
王子．
2 ）服部征雄：腸内細菌は漢方薬を活性化する．平成15年度（第10回）日本東洋医学会北陸支部特別講
演会・専門医制度夏期教育講演会， 2003, 7, 13，富山．
3 ）服部征雄：伝統医学と機能性食品一高齢化社会における果たす役割－ • 2003 8 6 島根県邑智郡邑
智町．
4) 服部征雄：和漢薬と腸内細菌のかかわり．第 8 回和漢薬研究所夏期セミナー， 2003, 8, 19-20，富
山県大山町．
5 ）服部征雄：ヒト腸内嫌気性菌による興味ある反応例について．大阪大学産業科学研究所・富山医科
薬科大学和漢薬研究所合同セミナー， 2003, 1, 26-27，富山．
6 ）服部征雄：抗ウイルス薬の開発研究. 2003, 12, 19，京都薬科大学．
7 ）服部征雄： 2003女子留学生日本語弁論大会審査委員長， 2003, 10, 20，富山市．
8 ）横津隆子：糖尿病性腎症の治療戦略一漢方方剤を中心として－．第49回東京女子医科大学漢方医学研
究会教育講演， 2003, 6, 18，東京女子医科大学．
9 ）横津隆子：腎疾患とフリーラジカル．新潟薬科大学大学院生薬・天然物化学特論セミナー， 2003, 6, 
27，新潟薬科大学．
10）横津隆子：冠元頼粒による老化抑制効果について．大阪中医薬研究会， 2003, 12, 7，大阪．
11）横津隆子：老化抑制効果が認められた新しい漢方薬．毎日ライフ 7月号， pp. 92-95, 2003. 
12) Nakagawa T., Yokozawa T.: Therapeutic Approach to Diabetic Nephropathy by the Chinese Prescription 
Keishi-bukuryo-gan. Proceedings of The 9th International Symposium on Traditional Medicine in Toyama 
2003, pp. 49-58, 2003. 
13）横津隆子：そばに含まれるポリフェノール類が腎機能低下に効果．日本薬学会ホームページ（トピッ
クス欄）， 2003, 10, 14. 
14）中村憲夫：抗 HIV 薬の開発研究．研究所セミナー（資源開発大部門制発足記念）' 2003, 12, 15，富
山医科薬科大学．
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く〉共同研究 Co・operative research 
1 ）下遠野邦忠（京都大学ウイルス研究所）下遠野久美子（共立薬科大学）垣内信子（金沢大学薬学
部）：「C 型肝炎 RNA ポリメラーゼ阻害活性を指標とした抗 HCV 剤の開発研究」
2 ）白木公康（富山医科薬科大学医学部）：「抗へルペスウイルス活性を有するタイ薬用植物の探索」
3 ）木谷健一（国立長寿医療センター）：「抗老化薬に関する研究」
4) 青柳一正（筑波技術短期大学），鄭海泳（国立釜山大学校薬学大学），田中 隆（長崎大学薬学部），
柏田良樹（新潟薬科大学）：「抗酸化に関する研究」
く〉非常勤講師 Part-time lecturer 
1 ）服部征雄：千葉大学薬学研究科， 4 月～9 月
2 ）横津隆子：富山大学， 4 月～8 月
く〉研究費取得状況 Acquisition of research funds 
1 ）日本科学協会平成15年度笹川科学研究助成（高江静代表） 50万円．
2 ）富山県受託研究「和漢薬・バイオテクノロジー研究」（継続服部分担） 39万円．
3 ）島根県川本農林振興センター受託研究「邑智霊芝の苦味成分の分析（継続，服部代表） 30万円．
4) つくし奨学・研究基金「加齢過程におけるフリーラジカルの役割と紅花の効果」（継続，横津代表）
120万円．
5 ）財団法人富山県新世紀産業機構平成15年度さきがけ研究開発助成金「柿ポリフェノールの低分子化
による健康食品素材の研究開発」（新規横津分担） 300万円．
6 ）平成15年度研究拠点形成費補助金（COE）「東洋の知に立脚した個の医療の創生」（服部分担） 250 
万円．
く〉受賞 Award 
1 ）横津隆子：第28回（2003年度）漢方研究イスクラ奨励賞「漢方薬から老化抑制の可能性を探る J . 
く〉学位および論文名 Academic degrees and theses 
課程博士（2003年 3 月）
謝麗華： Biotransformation of plant lignans (arctiin and pinoresinol diglucoside) to mammalian lignans by 
human intestinal microflora 
柳東泳：A novel activity of Chinese prescription. Wen-Pi-Tang and its component （ー）－epicatechin 3-0-
gallate against peroxynitrite-induced renal injury 
修士（2003年 3 月）
石田あし、：酸化ストレスにおける黄連の役割とその活性成分の探索
土屋真澄：ヒ卜腸内細菌を利用した（－）－enterolactone, （ー）－enterodiolの簡易合成法の開発
条美智子：中国少数民族の単純ヘルペスウイルス及び C 型肝炎ウイルスポリメラーゼ、阻害活性につ
いて
学士（2003年 3 月）
西畑友尋：ヒト腸内嫌気性細菌によるイソフラボン類の変換反応
く〉研究室在籍者 Research member 
4 年次学生：近藤直子，和田江美子、
大学院前期 1 年：西畑友尋
大学院前期 2 年：平川暁子，山辺典子
大学院後期 1 年：条美智子
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大学院後期 2 年：佐藤亜希子， Kanjana Sangul 
大学院後期 3 年：‘高江静，安恩美
外国人客員研究員：朴鐘詰（博士）, Park, Hye Jin （博士），越字峰，子超，左風（博士），
宋陸赫， Gafur, Md. Abdul （博士）, Khunkitti, W atcharee 
機関研究員：越静（博士）
受託研究員：山下範子
事務補佐員：黒岩純子
